Skip to main content

Find Clinical Trials

Home
Conditions
Communicable Diseases

Clinical trial condition

Communicable Diseases

Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.

9,174 public trials 549 recruiting studies

Refine in advanced search Browse all conditions

Communicable Diseases trial results

Completed

Reducing Hepatitis C Virus (HCV)/Human Immunodeficient Virus (HIV) Risk Behaviors Among Injection Drug Users in China

NCT01647191

Conditions: Blood-Borne Infections, Chemically-Induced Disorders, Communicable Diseases, +12 more
Locations: Shanghai Hong Kou MMT clinic Shanghai, Shanghai Municipality, China

Shanghai Yang Pu MMT clinic Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Women SHARE Study: Reducing Sexual Risk

NCT03323086

Conditions: Alcohol and Substance-Related Mental Disorders, Communicable Diseases, Disease Attributes, +6 more
Locations: Planned Parenthood of Southern New England Providence, Rhode Island, United States

View Trial Details

Completed

Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age).

NCT00352963

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +28 more
Locations: GSK Investigational Site Alcorcón, Spain

GSK Investigational Site Almeira, Spain

GSK Investigational Site Badalona, Spain

GSK Investigational Site Barcelona, Spain

View all 22 locations

View Trial Details

Completed

Safety and Immunogenicity of GlaxoSmithKline Biologicals' HPV Vaccine 580299 (Cervarix) in HIV Infected Females

NCT00586339

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +31 more
Locations: GSK Investigational Site Khayelitsha, South Africa

View Trial Details

Completed

Pharmacodynamics, Safety and Pharmacokinetics of BMS-663068, an HIV Attachment Inhibitor, in HIV-1

NCT01009814

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: GSK Investigational Site Berlin, Germany

View Trial Details

Completed

Immunogenicity and Safety of a Commercially Available Vaccine Co-administered With GSK HPV Vaccine (580299)

NCT00637195

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +30 more
Locations: GSK Investigational Site Ghent, Belgium

GSK Investigational Site La Louvière, Belgium

View Trial Details

Completed

Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age

NCT00970307

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +33 more
Locations: GSK Investigational Site Bydgoszcz, Poland

GSK Investigational Site Dębica, Poland

GSK Investigational Site Krakow, Poland

GSK Investigational Site Krakow, Poland

View Trial Details

Completed

Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older

NCT00294047

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +23 more
Locations: GSK Investigational Site Fountain Valley, California, United States

GSK Investigational Site Aurora, Colorado, United States

GSK Investigational Site Golden, Colorado, United States

GSK Investigational Site Coral Gables, Florida, United States

View all 75 locations

View Trial Details

Completed

Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines

NCT00463437

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +38 more
Locations: GSK Investigational Site Bad Saulgau, Baden-Wurttemberg, Germany

GSK Investigational Site Bönnigheim, Baden-Wurttemberg, Germany

GSK Investigational Site Bretten, Baden-Wurttemberg, Germany

GSK Investigational Site Ettenheim, Baden-Wurttemberg, Germany

View all 63 locations

View Trial Details

Completed

Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age

NCT00423046

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +23 more
Locations: GSK Investigational Site Chandler, Arizona, United States

GSK Investigational Site San Diego, California, United States

GSK Investigational Site San Francisco, California, United States

GSK Investigational Site Vista, California, United States

View all 40 locations

View Trial Details